GlassScriptPhysician profile
Ashley Weigle
NPI 1073941159
$6,067.74
in general payments reported to CMS, 2019-2025
47 companies · $1,235 in 2025
The $1,235 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,259 · 2022: $1,141 · 2023: $1,207 · 2024: $1,226 · 2025: $1,235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,668.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,667.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,128.09 | 2021-2025 | |
| Novo Nordisk INC | $945.02 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $725.15 | 2021-2025 | Farxiga, Airsupra |
| Pfizer INC. | $513.56 | 2021-2025 | |
| Lilly USA, LLC | $453.59 | 2021-2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $197.91 | 2023-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Amgen INC. | $184.74 | 2023-2025 | Repatha, Otezla, Repatha |
| Merck Sharp & Dohme LLC | $152.15 | 2021-2025 | Vaxneuvance, Gardasil 9, Pneumovax 23 |
| Sanofi Pasteur INC. | $150.80 | 2021-2024 | |
| Esperion Therapeutics, INC. | $145.08 | 2021-2025 | Nexletol |
| Bausch Health US, LLC | $140.74 | 2021-2023 | Aplenzin |
| Biohaven Pharmaceutical Holding Company LTD. | $121.63 | 2022 | |
| Astellas Pharma US INC | $80.58 | 2022-2025 | Veozah |
| Eisai INC. | $77.59 | 2021 | |
| Philips North America LLC | $76.58 | 2022-2024 | (Ck7) Extended Holter |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Weigle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.